Today is the launch of a study run by the National Immunisation Schedule Evaluation Consortium (NISEC) and backed by the UK Government’s Vaccines Taskforce, which will evaluate the feasibility of using a different vaccine for the initial ‘prime’ vaccination to the follow-up ‘booster’ vaccination.
Dr Mary Ramsay, Head of Immunisation at Public Health England
Prof Matthew Snape, Associate Professor in Paediatrics and Vaccinology, Oxford Vaccine Group, Chief Investigator on the trial
Dr Maheshi Ramasamy, Consultant Physician and Senior Clinical Researcher, Oxford Vaccine Group
Dr Andrew Ustianowski, Joint National Specialty Lead for Infection at NIHR Clinical Research Network
This Briefing was accompanied by an SMC Roundup of Comments.